This compound is a pharmaceutical impurity reference standard of levofloxacin, specifically a nitrosamine derivative identified as (2S)-7-fluoro-2-methyl-6-(4-nitrosopiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7. 3.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 1152314-62-9
Levofloxacin hydrate
active pharmaceutical ingredient
Ofloksasin
fluoroquinolone antibiotic
Ofloxacin
active pharmaceutical ingredient
Levofloksasin
active pharmaceutical ingredient
(2R,3S,4S,5S)-5-Hydroxy-2,3,4-tris(phenylmethoxy)-5-((phenylmethoxy)methyl)cyclohexanone
Pharmaceutical intermediate for synthetic building block
Tetrabenzyl-voglibose
Pharmaceutical intermediate for voglibose synthesis
2-(4-aminophenyl)-2-methylpropanenitrile
pharmaceutical intermediate
Glycidyl 3-nitrobenzenesulfonate
Pharmaceutical intermediate
(2S)-7-fluoro-2-methyl-6-(4-nitrosopiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid
GNTZPZBXVIOIQQ-VIFPVBQESA-N
C[C@H]1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)N=O)F)C(=O)O